Resisting in France and la vie inventée

The daily experience of resistance in occupied France has often been missing from accounts of les années noires. Whether concerned with the deeds of prominent resisters or with the deconstruction of national myths, history has often obscured the experiences of the majority of the significant minority who opted to rebel against oppression. The first two years of the Occupation are often overshadowed by the move towards a unified movement and the increasingly combative stance of the Resistance of the following years. This may be partly related to the difficulty in placing such disparate realities into a coherent methodological framework. Equally, an analysis of events that possessed a surreal and almost dreamlike quality by those that witnessed them may have discouraged attempts to gain a deeper awareness of the phenomenon of resistance. In some respects, it did occupy a different sphere of reality for those that chose not to obey the armistice could be considered marginal in their behaviour and their memory remained so in post-war France as the demands of national reconstruction produced a dominant representation of the period which obscured the experience of the individual. This paper seeks to explore this sub-reality through an analysis of la vie inventée and its manifestation within the creation of an ésprit de résistance, the transmission of this consciousness and the inversion of the hegemony of the Vichy régime. Finally, it will question whether this notion was born from or conversely a prerequisite to La Résistance

Verifying multi-partite mode entanglement of W states

We construct a method for verifying mode entanglement of N-mode W states. The ideal W state contains exactly one excitation symmetrically shared between N modes, but our method takes the existence of higher numbers of excitations into account, as well as the vacuum state and other deviations from the ideal state. Moreover, our method distinguishes between full N-party entanglement and states with M-party entanglement with M<N, including mixtures of the latter. We specialize to the case N=4 for illustrative purposes. In the optical case, where excitations are photons, our method can be implemented using linear optics.Comment: 11 pages, 12 figure

Deep Thermal Infrared Imaging of HR 8799 bcde: New Atmospheric Constraints and Limits on a Fifth Planet

We present new $L^\prime$ (3.8 $\mu m$) and Br-$\alpha$ (4.05 $\mu m$) data and reprocessed archival $L^\prime$ data for the young, planet-hosting star HR 8799 obtained with Keck/NIRC2, VLT/NaCo and Subaru/IRCS. We detect all four HR 8799 planets in each dataset at a moderate to high signal-to-noise (SNR $\gtrsim$ 6-15). We fail to identify a fifth planet, "HR 8799 f", at $r$ $<$ 15 $AU$ at a 5-$\sigma$ confidence level: one suggestive, marginally significant residual at 0.2" is most likely a PSF artifact. Assuming companion ages of 30 $Myr$ and the Baraffe (Spiegel \& Burrows) planet cooling models, we rule out an HR 8799 f with mass of 5 $M_{J}$ (7 $M_{J}$), 7 $M_{J}$ (10 $M_{J}$), and 12 $M_{J}$ (13 $M_{J}$) at $r_{proj}$ $\sim$ 12 $AU$, 9 $AU$, and 5 $AU$, respectively. All four HR 8799 planets have red early T dwarf-like $L^\prime$ - [4.05] colors, suggesting that their SEDs peak in between the $L^\prime$ and $M^\prime$ broadband filters. We find no statistically significant difference in HR 8799 cde's colors. Atmosphere models assuming thick, patchy clouds appear to better match HR 8799 bcde's photometry than models assuming a uniform cloud layer. While non-equilibrium carbon chemistry is required to explain HR 8799 bc's photometry/spectra, evidence for it from HR 8799 de's photometry is weaker. Future, deep IR spectroscopy/spectrophotometry with the Gemini Planet Imager, SCExAO/CHARIS, and other facilities may clarify whether the planets are chemically similar or heterogeneous.Comment: 18 pages, 6 Tables, and 9 Figures. Fig. 1a is the key figure. Accepted for publication in Ap

Establishing an academic biobank in a resource-challenged environment

Past practices of informal sample collections and spreadsheets for data and sample management fall short of best-practice models for biobanking, and are neither cost effective nor efficient to adequately serve the needs of large research studies. The biobank of the Sydney Brenner Institute for Molecular Bioscience serves as a bioresource for institutional, national and international research collaborations. It provides high-quality human biospecimens from African populations, secure data and sample curation and storage, as well as monitored sample handling and management processes, to promote both non-communicable and infectious-disease research. Best-practice guidelines have been adapted to align with a low-resource setting and have been instrumental in the development of a quality-management system, including standard operating procedures and a quality-control regimen. Here, we provide a summary of 10 important considerations for initiating and establishing an academic research biobank in a low-resource setting. These include addressing ethical, legal, technical, accreditation and/or certification concerns and financial sustainability

Establishing an academic biobank in a resource-challenged environment

Past practices of informal sample collections and spreadsheets for data and sample management fall short of best-practice models for biobanking, and are neither cost effective nor efficient to adequately serve the needs of large research studies. The biobank of the Sydney Brenner Institute for Molecular Bioscience serves as a bioresource for institutional, national and international research collaborations. It provides high-quality human biospecimens from African populations, secure data and sample curation and storage, as well as monitored sample handling and management processes, to promote both non-communicable and infectious-disease research. Best-practice guidelines have been adapted to align with a low-resource setting and have been instrumental in the development of a quality-management system, including standard operating procedures and a quality-control regimen. Here, we provide a summary of 10 important considerations for initiating and establishing an academic research biobank in a low-resource setting. These include addressing ethical, legal, technical, accreditation and/or certification concerns and financial sustainability

The Effects of Ketorolac Injected via Patient Controlled Analgesia Postoperatively on Spinal Fusion

Lumbar spinal fusions have been performed for spinal stability, pain relief and improved function in spinal stenosis, scoliosis, spinal fractures, infectious conditions and other lumbar spinal problems. The success of lumbar spinal fusion depends on multifactors, such as types of bone graft materials, levels and numbers of fusion, spinal instrumentation, electrical stimulation, smoking and some drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs). From January 2000 to December 2001, 88 consecutive patients, who were diagnosed with spinal stenosis or spondylolisthesis, were retrospectively enrolled in this study. One surgeon performed all 88 posterolateral spinal fusions with instrumentation and autoiliac bone graft. The patients were divided into two groups. The first group (n=30) was infused with ketorolac and fentanyl intravenously via patient controlled analgesia (PCA) postoperatively and the second group (n=58) was infused only with fentanyl. The spinal fusion rates and clinical outcomes of the two groups were compared. The incidence of incomplete union or nonunion was much higher in the ketorolac group, and the relative risk was approximately 6 times higher than control group (odds ratio: 5.64). The clinical outcomes, which were checked at least 1 year after surgery, showed strong correlations with the spinal fusion status. The control group (93.1%) showed significantly better clinical results than the ketorolac group (77.6%). Smoking had no effect on the spinal fusion outcome in this study. Even though the use of ketorolac after spinal fusion can reduce the need for morphine, thereby decreasing morphine related complications, ketorolac used via PCA at the immediate postoperative state inhibits spinal fusion resulting in a poorer clinical outcome. Therefore, NSAIDs such as ketorolac, should be avoided after posterolateral spinal fusion